fda compounding semaglutide warning september 2025 30 telehealth companies received U.S. Food and Drug Administration letters for falsely marketing GLP-1 products online. said these companies claimed that their compounded products are similar to generic FDA-approved products FDA alerts health care providers,

They use the same active ingredient as the injectable but in a daily tablet

IGF-1 LR3 plays an important role in cell proliferation, cell-to-cell communication and cell division.IGF-1 LR3 is a derivative of IGF-1

More than 80% achieved at least 15% weight loss, supporting ongoing investigation in pharmacologic obesity management

Consider behavioural support such as cognitive behavioural therapy (CBT) or structured weight management programmes, which are recommended within NICE obesity guidelines (CG189, PH53) as adjuncts to pharmacological treatment

For women in perimenopause and menopause, dosing decisions should follow a structured evaluation